| Table 2. miRNAs differentially detected in the serum of patients to be submitted to COS for ART cycles | |||||
| miRNA ID | CT value | Fold Change | |||
| NR | PR | HR | PR vs. NR | HR vs. NR | |
| hsa-miR-99a-5p | n.d. | n.d. | 36.661 | - | 8.60 |
| hsa-miR-181d-5p | n.d. | n.d. | 31.444 | - | 52.99 |
| hsa-miR-221-3p | n.d. | n.d. | 35.203 | - | 3.91 |
| hsa-miR-92a-1-5p | n.d. | n.d. | 34.994 | - | 4.52 |
| hsa-miR-1302 | n.d. | n.d. | 34.614 | - | 21.67 |
| hsa-miR-150-5p | n.d. | 35.811 | n.d. | 13.60 | - |
| hsa-miR-223-3p | n.d. | 35.933 | n.d. | 16.76 | - |
| hsa-let-7d-3p | n.d. | 36.662 | n.d. | 10.11 | - |
| hsa-miR-891a-5p | n.d. | 34.248 | n.d. | 40.1 | - |
| hsa-miR-99a-3p | n.d. | 36.335 | n.d. | 9.01 | - |
| hsa-miR-200c-5p | n.d. | 34.829 | n.d. | 36.03 | - |
| n.d.=not detectable; Ct value=cycle threshold value, cycle where fluorescence level exceeds detection threshold; NR=normal response; PR=poor response; HR=hyperresponse. | |||||